期刊文献+

早期集束化治疗在经皮肾镜碎石术后感染性休克患者的应用价值 被引量:13

Clinical application value of early bundle therapy in patients with septic shock after percutaneous nephrolithotomy
下载PDF
导出
摘要 目的探索早期集束化治疗在经皮肾镜碎石(PCNL)术后感染性休克患者的应用价值。方法回顾性分析2011年1月至2013年9月因PCNL术后并发感染性休克入住该院中心ICU的患者,根据是否采取感染性休克集束化治疗分为非集束化治疗组28例,集束化治疗组26例。比较两组患者治疗前、治疗后第1、3、5天APACHE-Ⅱ评分和SOFA评分,ICU停留时间情况。根据28d随访结果比较两组患者病死率。结果同非集束化治疗组比较,集束化治疗组第1、3、7天APACHE-Ⅱ评分和SOFA评分均明显降低,差异有统计学意义(P<0.05)。随访28d,集束化治疗组患者病死率(15.38%)明显低于非集束化治疗组(35.71%),差异有统计学意义(P<0.05)。非集束化治疗组和集束化治疗组患者ICU停留时间分别为(9.04±4.48)d和(7.00±2.32)d,差异有统计学意义(P<0.05)。结论早期集束化治疗有利于减轻PCNL术后感染性休克患者病情严重程度,减少病死率。 Objective To explore the clinical application value of early bundle therapy in patients with septic shock after per‐cutaneous nephrolithotomy(PCNL) .Methods The retrospective analysis was conducted patients with septic shock after PCNL ad‐mitted to the central ICU of the First Affiliated Hospital ,University of South China from January 1st ,2011 to september 30 ,2013 . The patients were divided into non‐bundle therapy group and bundle therapy group according to whether treated by early bundle therapy .the APACHE‐Ⅱscore and SOFA score in the before and 1 ,3 ,7 d after treatment ,mortality rate within 28 d and length of ICU were compared with both groups .Results 54 patients were enrolled in the study ,there were 28 and 26 patients in non‐bundle therapy group and bundle therapy group ,respectively .The clinical data of patients in both groups had no significant difference be‐tween the groups ,all P〉0 .05 .Compared with the patients in non‐bundle therapy group ,the APACHE‐Ⅱscore and SOFA score in 1 ,3 ,7 d after treatment significantly decreased in bundle therapy group ,all P〈0 .05 .mortality rate in bundle therapy group and non‐bundle therapy group were 15 .38% and 35 .71% ,respectively ,P〈0 .05 ;and length of ICU were(9 .04 ± 4 .48)d and(7 .00 ± 2 .32)d ,respectively ,P〈0 .05 .Conclusion Early bundle therapy can effectively alleviate the severity of the disease and reduce mor‐tality of patients with septic shock after PCNL .
出处 《重庆医学》 CAS 北大核心 2015年第8期1039-1040,1043,共3页 Chongqing medicine
基金 湖南省医药卫生科研计划课题基金资助项目(B2013-040)
关键词 经皮肾镜碎石术 感染性休克 集束化治疗 percutaneous nephrolithotomy septic shock bundle therapy
  • 相关文献

参考文献11

  • 1Vorrakitpokatorn P, Permtongchuchai K, Raksamani EO, et al. Perioperative complications and risk factors of per cutaneous nephrolithotomy[J]. J Med Assoc Thai, 2006, 89(6) :826-833.
  • 2Wang Y,Jiang F,Wang Y, et al. Post-percutaneous neph- rolithotomy septic shock and severe hemorrhage: a study of risk faetors[J]. Urol Int,2012,88(3) :307-310.
  • 3Aron M, Yadav R, Goet R, et al. Multi-tract percutaneous nephrolithotomy for large complete staghorn calculi [J]. Urol Int,2005,75(4) :327-332.
  • 4Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign:international guidelines for management of se vere sepsis and septic shock, 2012 [J]. Intensive Care Med,2013,39(2) :165-228.
  • 5Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ES- ICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003,31 (4) : 1250-1256.
  • 6Vincent JL, Van Nuffelen M. Septic shock: new pharma cotherapy options or better trial design? [J]. Expert Opin Pharmacother, 2013,14(5) : 561-570.
  • 7甄洪涛,蔡懿,张杰,蔡宪安,陈夏,王继征.经皮肾镜碎石术后并发感染性休克的处理与预防[J].实用医学杂志,2012,28(23):3959-3960. 被引量:7
  • 8O'Keeffe NK, Mortimer AJ, Sambrook PA, et al. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones[J]. Br J Urol, 1993,72(3) : 277- 283.
  • 9喻莉,龙鼎,许涛,张远超,杨军辉,耿峰.严重感染和感染性休克早期集束化治疗临床分析[J].中国现代医学杂志,2010,20(23):3632-3634. 被引量:17
  • 10瞿星光,张朝晖,周刚,龚勋,张蓉,曾超,李灵丰,刘静兰,梁永会,杨琳,李雯琪.以集束化治疗为核心的临床路径在感染性休克患者中的应用[J].海南医学,2012,23(2):7-10. 被引量:7

二级参考文献31

  • 1何征宇,皋源,王祥瑞,杭燕南.早期目标导向治疗在感染性休克中应用的临床探讨[J].中国危重病急救医学,2007,19(1):14-16. 被引量:32
  • 2成人严重感染与感染性休克血流动力学监测及支持指南(草案)[J].中国危重病急救医学,2007,19(3):129-133. 被引量:87
  • 3Talmor D, Greenberg D, Howell MD, et al. The costs and cost-effectiveness of an integrated sepsis treatment protocol.Crit Care Med, 2008,36 : 1168-1174.
  • 4De Miguel-Yanes JM, Andueza-Lillo JA, González-Ramallo VJ, et al. Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med, 2006,24:553-559.
  • 5Varpula M, Tallgren M, Saukkonen K, et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med,2005,31:1066-1071.
  • 6Nguyen HB,Lynch EL,Mou JA,et al. The utility of a quality improvement bundle in bridging the gap between research and standard care in the management of severe sepsis and septic shock in the emergency department. Acad Emerg Med, 2007,14:1079-1086.
  • 7Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med, 2008,34:17-60.
  • 8Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference.Crit Care Med,2003,31:1250-1256.
  • 9Angus DC,Linde-Zwirble WT,Lidicker J,et al. Epidemiology of severe sepsis in the United States: analysis of incidence,outcome, and associated costs of care. Crit Care Med, 2001,29:1303-1310.
  • 10Ferrer R,Artigas A,Levy MM,et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA, 2008,299 : 2294-2303.

共引文献43

同被引文献93

引证文献13

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部